Cowen and Company’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-64,011
| Closed | -$223K | – | 614 |
|
|
2022
Q4 | $223K | Sell |
64,011
-152,430
| -70% | -$532K | 0.02% | 159 |
|
|
2022
Q3 | $8.01M | Sell |
216,441
-850,413
| -80% | -$31.5M | 0.77% | 30 |
|
|
2022
Q2 | $20.3M | Sell |
1,066,854
-97,507
| -8% | -$1.85M | 1.96% | 13 |
|
|
2022
Q1 | $31.4M | Buy |
1,164,361
+1,014,587
| +677% | +$27.4M | 3.02% | 7 |
|
|
2021
Q4 | $3.37M | Sell |
149,774
-9,859
| -6% | -$222K | 0.31% | 61 |
|
|
2021
Q3 | $4.18M | Hold |
159,633
| – | – | 0.2% | 50 |
|
|
2021
Q2 | $5.11M | Sell |
159,633
-7,309
| -4% | -$234K | 0.27% | 42 |
|
|
2021
Q1 | $5.88M | Buy |
+166,942
| New | +$5.88M | 0.4% | 28 |
|